Lotte Chemical Corporation (011170) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Sep, 2026Executive summary
Q1 2025 revenue was KRW 4.9018 trillion, up 0.1% sequentially but down from KRW 5.09 trillion YoY, with operating loss narrowing to KRW 126.6 billion and net loss at KRW 246.3 billion, improved from the prior quarter due to absence of one-off costs.
Asset-light strategies, financial restructuring, and portfolio upgrades improved financial indicators, including reduced borrowings and lower debt ratios.
All major business segments reported negative or reduced operating income, with advanced and fine chemicals improving, while basic chemicals and battery materials posted significant losses.
The company maintained a strong cash position (KRW 3.6194 trillion) and total assets of KRW 34.76 trillion as of March 31, 2025.
Major investments and projects are underway in Indonesia, Korea, the US, Spain, and Malaysia, focusing on hydrogen, battery materials, and chemical recycling.
Financial highlights
EBITDA improved to KRW 173 billion, up from 74.1 billion KRW in 4Q24.
Cash and equivalents increased to KRW 3.6194 trillion; borrowings decreased to KRW 9.9925 trillion.
Debt ratio declined to 71.5%; net debt ratio improved to 31.4%.
EPS was -4,525 KRW; gross margin was 3.5%.
Inventory turnover was 6.64 times.
Outlook and guidance
Q2 performance expected to remain flat due to external uncertainties and scheduled plant maintenance.
Gradual year-over-year improvement anticipated as global ramp-up pressure eases and feedstock prices stabilize.
Turnaround to positive cash flow projected for the year, with investment execution within EBITDA possible from next year.
Basic chemicals expect stable profitability despite maintenance; advanced materials anticipate steady performance amid US tariff policy.
Management is focused on cost control, portfolio transformation, and new growth areas.
Latest events from Lotte Chemical Corporation
- Q2 2024 sales rose, losses narrowed, and strategic investments in hydrogen and batteries continued.011170
Q2 2024 - Impairment losses led to deep 2024 losses, but gradual recovery and asset-light progress are expected.011170
Q4 2024 - Q3 2024 revenue was flat, losses widened, and asset sales and investments continue amid weak demand.011170
Q3 2024 - Losses widened, but recovery is expected as portfolio shifts and new projects progress.011170
Q2 2025 - 2025 saw losses from weak demand and impairments, but recovery is expected through diversification.011170
Q4 2025 - Q3 2025 returned to profit, but 9M results show losses; focus shifts to battery and hydrogen.011170
Q3 2025 - Q2 2026 delivered higher profits and restructuring progress, despite ongoing market risks.011170
Q2 2026 - Q1 2026 returned to profit with KRW 4.99T revenue and KRW 49.6B net income amid ongoing risks.011170
Q1 2026